Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies

Many broadly neutralizing antibodies (bNAbs) against human immunodeficiency virus type 1 (HIV-1) were shown effective in animal models, and are currently evaluated in clinical trials. However, use of these antibodies in humans is hampered by the rapid emergence of resistant viruses. Here we show tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuka, Yuka, Schmitt, Kimberly, Quinlan, Brian D., Gardner, Matthew R., Alfant, Barnett, Reich, Adrian, Farzan, Michael, Choe, Hyeryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117093/
https://www.ncbi.nlm.nih.gov/pubmed/30125330
http://dx.doi.org/10.1371/journal.ppat.1007238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117093/
https://www.ncbi.nlm.nih.gov/pubmed/30125330
http://dx.doi.org/10.1371/journal.ppat.1007238

Ejemplares similares